DSCI ascends, MSFT steady, TZOO mauled

Derma Sciences Inc. (Nasdaq: DSCI) shares traveled 39.3 percent Thursday to $9.29 Thursday, on volumes of 494,316, compared to its full-day average of around 27,000, after learning its diabetic foot-wound drug met their mid-stage trial goal.

Microsoft Corporation (Nasdaq: MSFT) bought and sold 34.3 million Thursday, trailing its all-day average of 59.4 million. Share prices dipped back 1.1 percent to $27.63, after announcing MSFT may use a sale of debt products to reward shareholders.

Travelzoo Inc. (Nasdaq: TZOO) fell in price 15.6 percent to $44.52 Thursday. Volume was 1.3 million compared to a daily average of 281,000, after announcing quarterly EPS of 23 cents, compared to nine cents in the prior-year quarter.

Tags: buzz stocks, DSCI, healthcare, msft, nasdaq, technology, Technology Stocks, TZOO

This entry was posted on Thursday, February 3rd, 2011 at 2:38 pm by Glenn and is filed under Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.